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Faye C Morris1, Timothy J Knowles2, Adam F Cunningham1, Jeffrey A Cole3 and Ian R Henderson1*Abstract
Background: It is widely believed that laboratory strains of Escherichia coli, including those used for industrial
production of proteins, do not secrete proteins to the extracellular milieu.
Results: Here, we report the development of a generalised module, based on an E. coli autotransporter secretion
system, for the production of extracellular recombinant proteins. We demonstrate that a wide variety of structurally
diverse proteins can be secreted as soluble proteins when linked to the autotransporter module. Yields were
comparable to those achieved with other bacterial secretion systems.
Conclusions: The advantage of this module is that it relies on a relatively simple and easily manipulated secretion
system, exhibits no apparent limitation to the size of the secreted protein and can deliver proteins to the
extracellular environment at levels of purity and yields sufficient for many biotechnological applications.
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Escherichia coli is the preferred host for recombinant
protein production (RPP) in both a research and indus-
trial setting. The popularity of E. coli stems from attri-
butes that include high growth rates in inexpensive
media, high product yields, simple process scale-up and
safety [1]. The choice of alternative hosts for RPP is pre-
dicated on the inability of E. coli to achieve adequate
production of a target protein. A predominant reason
for the selection of an alternative host is the apparent in-
ability of laboratory strains of E. coli to secrete proteins
to the extracellular milieu. Targeting recombinant pro-
teins to the culture medium has several advantages over
intracellular accumulation of the desired protein includ-
ing overcoming problems with product toxicity, degrad-
ation, aggregation and incorrect folding [1,2]. In
principle, it will reduce the number of downstream pro-
cessing steps due to the ease of product recovery, the re-
duction in the number and quantity of process
impurities and absence of laborious refolding experi-
ments to isolate an active molecule [1].* Correspondence: i.r.henderson@bham.ac.uk
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distribution, and reproduction in any mediumSeveral non-specific strategies for extracellular accu-
mulation of recombinant proteins have been developed
for E. coli including genetically or chemically altering
strains to promote protein leakage from the periplasmic
space to the culture medium [3,4]. Unfortunately, this
results in large numbers of process impurities in the
form of lipids, polysaccharides and proteins derived from
the periplasm space and outer membrane (OM). Con-
versely, if bacterial secretion systems could be manipu-
lated to selectively secrete a desired target protein into
the culture medium, in a controlled and predictable
manner, it would drastically reduce costs and increase
efficiency in bioprocessing [5]. The bacterial type 1, 2, 3
and chaperone-usher systems have been manipulated to
secrete foreign proteins from E. coli and other Gram-
negative bacteria [6-9]. However, their use for RPP is
hampered by the debatable nature of the secretion
signals, their molecular complexity (which results in
species and/or substrate specificity) and the limited ac-
cumulation of the target protein [2]. Extensive genetic
manipulation is required to make these systems
tractable.
In contrast, the Type 5, or Autotransporter (AT), sys-
tem has been utilised widely to successfully secrete a
variety of heterologous target molecules to the bacterialCentral Ltd This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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are widely distributed among Gram-negative bacteria
[15-17]. The precursor protein contains an N-terminal
signal sequence, which mediates Sec-dependent protein
export into the periplasm, a passenger domain encoding
the effector function and a C-terminal domain mediat-
ing translocation of the passenger domain across the
OM [16,18,19]. The effector portion of the molecule
displays functional and structural heterogeneity and can
be substituted with heterologous proteins [14,16].
Whilst successful in delivering a diverse variety of mole-
cules to the cell surface, the AT system has not been
successfully adapted for accumulation of heterologous
proteins in the culture medium. The system can be
engineered to release the heterologous passenger pro-
tein into the culture medium with the use of a protease
[14], but the use of such proteases is undesirable for
production technologies. Here we demonstrate that an
AT module can be utilised not only for cell surface dis-
play but also for the accumulation of heterologous pro-
teins in the culture medium without the addition of
exogenous protease.
Results
Extracellular accumulation of heterologous proteins
Other groups have demonstrated the utility of ATs for
Autodisplay of heterologous proteins on the bacterial
cell surface [14]. In this case the passenger domain
remains covalently attached to the β-barrel translocat-
ing subunit. Unlike the ATs used for Autodisplay,
cleavage of the passenger domain of the serine prote-
ase ATs of the Enterobacteriaceae (SPATEs) from their
cognate β-barrel is effected by nucleophilic attack of
β-barrel residues on a single residue in the α-helix
[20]. As such, no exogenous protease is required for
liberation of the passenger domain from the β-barrel
and in theory the passenger domain can be completely
replaced with a target protein. Thus, we hypothesised
that the SPATEs could be used to target heterologous
proteins to the extracellular milieu rather than the cell
surface. To test this hypothesis, initial experiments fo-
cused on the E. coli SPATE protein, Pet [21]. When
compared to other members of the SPATE family Pet
possesses high amino acid sequence identity and
structural similarity: the passenger domain consists of
a central β-helical stem decorated with several discur-
sive subdomains and is connected to the characteristic
β-barrel by a short α-helical peptide (Additional file 1:
Figure S1). The gene encoding Pet was synthesised de
novo (Additional file 2: Figure S2) and cloned into
the pASK-IBA33plus or pET22b expression vectors
to create plasmid templates onto which the genes
encoding heterolgous proteins could be grafted for
further experiments.To test the ability of Pet to mediate secretion of heterol-
ogous proteins into the culture medium we chose proteins
with distinctive size, structural and functional signatures.
These included the secreted portions of (a) Pertactin from
Bordetella pertussis, a component of the acellular whoop-
ing cough vaccine (43.9 kDa), (b) YapA, a surface protein
from Yersinia pestis (105.2 kDa), (c) Pmp17, a poly-
morphic surface protein from Chlamydophila abortus
(40 kDa), (d) SapA, a putative surface protein from
Salmonella enterica serovar Typhimurium (60.7 kDa),
(e) the red fluorescent protein mCherry, a derivative of
Discosoma sp DsRed (26.7 kDa), (f) the predicted secreted
esterase Ag85B , a putative Mycobacterium tuberculosis
vaccine candidate (34.6 kDa) and (g) ESAT-6 the major
diagnostic marker from M. tuberculosis (10 kDa)
[17,22-25]. DNA encoding the heterologous proteins was
synthesized de novo after codon optimization for expres-
sion in E. coli (Additional file 2: Figure S2). Previous Auto-
display experiments suggested the N-terminal portion of
AT passenger domains were not required for secretion of
heterologous proteins to the bacterial cell surface [14]. To
verify if this was also the case for proteins released into
the culture medium, different parts of the pet gene were
replaced in-frame with heterologous DNA to give rise to
fusion proteins as shown in Figure 1A. All of the chimeric
proteins were secreted into the culture medium as soluble
proteins at levels stoichiometrically similar to the wild-
type Pet protein (Figure 1B) confirming the N-terminal
portions of the passenger domain are not required for
secretion. Similarly, the cleaved β-barrel accumulated
in the OM at levels indistinguishable from wild-type
protein (Additional file 3: Figure S3). To authenticate
the identities of all secreted proteins, bands were
excised from polyacrylamide gels and subjected to
mass spectrometry; the appropriate protein was con-
firmed in each case (Additional file 4: Table S1). Fi-
nally, yields of Pertactin and ESAT-6 from Pet fusion
constructs in shake flasks were calculated and
accounted for as much as 5% total cell protein, de-
pending on the expression strain and conditions. For
ESAT6-Pet variants and Pertactin-Pet concentrations
of 5.4 and 1mg/l respectively were achieved after ex-
pression in E. coli BL21*.
Heterologous proteins are secreted
To demonstrate that the presence of heterologous pro-
teins in the culture medium was due to secretion rather
than leakage from the periplasm or cell lysis, we exam-
ined the cellular location of mCherry and ESAT-6. Re-
cently, we described a mutation in Pet (Pet*) that
disrupts the interdomain cleavage site such that the pas-
senger domain is completely translocated to the cell sur-
face but remains covalently attached to the β-domain
[26]. This mutation was introduced into mCherry-Pet-BP
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Figure 1 AT-mediated accumulation of heterologous proteins in the culture medium. (A) Schematic diagram of Pet fusion constructs.
Heterologous protein insertions in the Pet passenger domain are shown by dark boxes marked HP or with the name of the protein, and are also
listed on the right. Abbreviations BB and BP on the left refer to the type of protein fusion generated by insertion of foreign DNA into the pet
gene between the restriction sites BglII and BstBI or BglII and PstI, respectively. The co-ordinates above the figure are given for the amino acids
derived from the de novo synthesised pet gene. The positions of these sites in the context of the quaternary structure are depicted in Additional
file 1: Figure S1. The arrow at position 1018 denotes the cleavage site in the α-helix that effects release of the passenger domain into the culture
medium. Modification of this site results in surface display of molecules (Figure 2). The abbreviations SS, AC and α denote the positions of the
signal sequence, autochaperone domain and α-helix, respectively. (B) The presence of secreted heterologous proteins in the culture medium was
detected by SDS-PAGE or immunoblotting with anti-Pet. Equivalent volumes of medium were analysed. The structures of several heterologous
proteins are depicted (not to scale). (C) Investigation of the folded state of secreted heterologous fusion proteins. Far-UV CD spectra of Pet and
several heterologous proteins are shown in millidegrees (mdeg). mCherry-Pet-BP harvested from the culture supernatant is shown.
Sevastsyanovich et al. Microbial Cell Factories 2012, 11:69 Page 3 of 10
http://www.microbialcellfactories.com/content/11/1/69and ESAT6-Pet-BB to create mCherry* and ESAT6*,
respectively. In each case no passenger domain accumu-
lates in the culture medium and full length versions can
be detected in the OM (Figure 2A and Additional file 5:
Figure S4). Immunofluorescence studies of bacteria
expressing Pet*, mCherry* and ESAT6* with specificantibodies revealed surface localisation of passenger
domains whereas with the native cleavage site there was
negligible staining and protein accumulated in
the medium (Figure 2B and Figure 1B). Flow cytom-
etry confirmed these observations (Additional file 5:
Figure S4). These experiments demonstrate that the
A B C
D
Figure 2 Monitoring cellular integrity of the E. coli host strain expressing AT chimeras. (A) SDS-PAGE analysis of OM (M) and culture
supernatant (S) fractions derived from E. coli TOP10 expressing Pet*, mCherry*and ESAT6*. Non cleaved species are denoted by arrows. Molecular
weight markers (MWM, kDa) are indicated to the right of the panel. OM fractions demonstrating the presence and absence of the β-domain are
shown in Additional file 6: Figure S5. (B) E. coli cells expressing empty vector, Pet*, mCherry*, ESAT6* and their cleaved parents were harvested
2 h after induction and subjected to indirect immunofluorescence using the indicated antibody. For each population expressing a cleavage
deficient variant, a sample was divided in two: one half was probed with an antibody to the periplasmic protein BamD, while the other half was
permeabilised (−P) and subsequently probed with the same antibody. Corresponding fields are also shown by phase contrast microscopy. For
the mCherry constructs panels showing mCherry derived fluorescence are shown. (C) The integrity of E. coli host cells expressing wild type Pet
and secreted ESAT6-Pet fusions were assessed by staining with BOX and PI prior to and 2 h post induction. Q3 represents the population that is
viable and healthy and did not label with either stain. Q2 represents cells that stain with both stains and are no longer viable. Q4 (BOX-positive)
represents cells with impaired membrane potential suggesting compromised membrane integrity. (D) Periplasmic leakage from E. coli TOP10
cultures secreting Pet or ESAT6-Pet fusion proteins was assessed by measuring (2 h after induction) the activity in the culture medium of the
periplasmic enzyme alkaline phosphatase. Clarified whole cell lysate was used as a positive control and the wild-type plasmid-free strain as a
negative control. There is no significant difference between the negative control and culture medium derived from strains expressing Pet or
ESAT6-Pet-BB. In contrast, culture medium from both constructs displayed activity significantly less than the positive control. Absorbance
measurements are derived from equal volumes of culture and are normalised relative to positive control (in %). The error bars represent standard
error for two independent data sets.
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cated to the cell surface before cleavage. Crucially, prob-
ing with antibodies directed at the periplasmic protein
BamD [27] revealed labelling was not due to ingress of
antibodies into the bacterial cell since cells did not label
unless permeabilised by chemical treatment (Figure 2B);
hence secretion occurred without major loss of mem-
brane integrity. To ensure proteins were not released
into the culture medium by cell lysis upon induction
of expression, staining with propidium iodide (PI)
and Bis-(1,3-dibutylbarbituric acid) trimethine oxonol
(BOX) was used to assess cell viability and the integ-
rity of the cell envelope of bacteria secreting heterol-
ogous fusions. Importantly, flow cytometry analyses ofcultures expressing ESAT6-Pet-BB, ESAT6-Pet-BP and
Pet proteins revealed that the majority of cells remain
healthy and alive during protein secretion with only
negligible increases in the number of BOX- or PI +
BOX-positive cells after induction of protein expression
compared to uninduced cultures (Figure 2C). Finally,
assays for alkaline phosphatase, a periplasmic enzyme,
demonstrate no leakage of periplasmic proteins after ex-
pression of heterologous fusions (Figure 2D). Taken to-
gether these data indicate that the presence of secreted
proteins in the culture media is not due to cell lysis or
periplasmic leakage, but active secretion. Additionally,
the presence of ESAT-6 and fluorescent mCherry on the
bacterial cell surface of cultures expressing mCherry*
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cleavage site, can also be used for autodisplay of func-
tional proteins (Figure 2B).
Secreted proteins are soluble, folded and can be modified
To be useful as a method of RPP, the AT system must be
able to secrete soluble, folded and functional proteins
into the culture medium. To test if the chimeric proteins
were natively folded after secretion, we harvested the
proteins from the culture supernatant fractions and sub-
jected them to analysis by circular dichroism (CD)
(Figure 1C). The structure of YapA is unknown, however
bioinformatic analyses predicted YapA to possess a
mixed α-helical/β-strand conformation whereas struc-
tural data reveal mCherry adopts a β-barrel conform-
ation [24]. CD spectra of YapA showed minima at
222 nm and 208 nm and maxima at 195 nm indicative
of a folded protein with mixed α-helical/β-strand con-
tent. Consistent with their natively folded β-strand con-
formations, CD spectra for Pet and mCherry show
minima at 218 nm and maxima at 195 nm. Additionally,
mCherry purified from the culture supernatant fraction
shows fluorescence indicating a folded protein with
functional activity (Figure 1C).
Having established the Pet AT system can support the
specific secretion of some heterologous proteins in a
folded and functional state, we investigated whether the
system could secrete modified chimeras consisting of
proteins with disulphide bonded cysteine residues, puri-
fication tags or multiprotein complexes. Proteins targeted
for secretion by the AT mechanism have to traverse the
periplasm, a highly oxidising cellular compartment whereA
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Figure 3 Modification of the Pet-AT secretion platform. (A) SapA, Pmp
domain were modified to add a His6-Tag to the N-terminus of the secreted
an E. coli TOP10 dsbA strain and the rest of proteins were produced in the
cysteine-containing Pmp17 was expressed in E. coli TOP10 (wt) and a dsbA
derivative but not the E. coli TOP10 parent strain. Break down products are
multicomponent construct was created by fusing DNA encoding Ag85 to E
contiguous with the AT-translocation unit. This latter chimera was detected
Equivalent amounts of culture supernatant fractions were analysed by SDS
Culture medium from S. enterica SL1344 strains expressing ESAT6-Pet-BP an
PAGE and detected by immunoblotting with a polyclonal antibody to ESAT
(MWM, kDa) are depicted at the right side of the panel. The equivalent OM
shown in Additional file 5: Figure S4.formation of disulphide bonds between cysteine residues
is catalysed by DsbA [28]. Pmp17-Pet-BB, possessing 7
cysteines, was expressed in E. coli TOP10 dsbA and
accumulated in the culture medium at levels consistent
with wild-type Pet (Figure 3A). No full-length protein
could be detected in wild-type E. coli TOP10. However,
degradation products were observed in the extracellular
milieu. These products are consistent with a degraded
passenger domain lacking the ca. 24 kDa N-terminal
region containing the cysteines and based on previous
experiments is the result of the action of the periplasmic
protease DegP [26,29]. When the N-terminal region
containing the cysteines is removed by DegP-mediated
degradation the disulphide bonds cannot form and se-
cretion is no longer stalled. These results are consistent
with observations made for Pet and other ATs that dem-
onstrate disulphide bond formation and partial folding
of native or heterologous polypeptides hinders their se-
cretion [26,29,30]. Fusion tags might be desirable for
downstream purification applications. N-terminal addition
of a His6-tag to the SapA and Pmp17 passenger domains,
as well as on wild-type and truncated Pet derivatives, did
not interfere with secretion of target proteins to the extra-
cellular milieu (Figure 3A). Previously, we demonstrated
the system is capable of secreting proteins with HA- and
FLAG-tags [26]. Notably, the multicomponent chimera
containing both Ag85B and ESAT-6 proteins could also
be secreted by Pet (Figure 3A). To determine whether the
AT module can be utilised for production of heterologous
proteins in other Gram-negative bacteria we investigated
expression of ESAT6-Pet-BP and ESAT6-PetΔ*6 (see
below) in S. Typhimurium SL1344 and its avirulentB
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17, Pet and a Pet derivative (PetΔD1) lacking the serine protease
passenger domain. The His-tagged Pmp17 protein was expressed in
wild-type E. coli TOP10. In all cases the proteins are well secreted. The
- derivative. A full length protein is present in the E. coli TOP10 dsbA-
apparent and correspond to proteins with a truncated N-terminus. A
SAT-6 and Pet (see Figure 1A) to encode a single polypeptide chain
in the culture supernatant with antibodies directed at Pet and ESAT-6.
-PAGE. (B) Secretion of heterologous fusions from S. Typhimurium.
d ESAT6-PetΔ*6 (see Figure 4) were harvested and analysed by SDS-
-6. In all SDS-PAGE gels the positions of the molecular weight markers
fractions demonstrating the presence of the cleaved β-barrel are
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into the culture medium at levels similar to that for Pet
(Figure 3B). These data demonstrate the versatility of the
Pet AT-module for secreting proteins and multiprotein
complexes into the culture medium.
Determination of the minimal construct mediating
secretion
The constructs described above possessed at least 100
amino acids upstream of the predicted Pet β-barrel.
This stretch of amino acids encompasses the α-helical
peptide spanning the β-barrel lumen and the Autocha-
perone (AC) domain. Previously, the AC domain has
been implicated in secretion of passenger domains,
where contemporaneous folding of the β-helix and a
Brownian ratchet mechanism provide the vectorial im-
petus for secretion [31,32]. Here we sought to deter-
mine the precise length of the minimal functional
translocation domain for Pet and determine whether
the AC-domain is required for secretion of heterol-
ogous proteins to the growth medium. To this end, we
examined secretion of ESAT-6-Pet-BP and 20 deriva-
tives harbouring sequential truncations (Figure 4 and
Additional file 6: Figure S5). All Pet derivatives, includ-
ing the smallest variant tested that contains only the
predicted α-helix and the downstream β-barrel domain,
could sustain ESAT-6 secretion into the cultureA
B
Figure 4 Identification of the minimal AT module permitting secretio
(A) Schematic of ESAT6-Pet-BP protein fusion and some truncations create
secretion. The Δ*1, Δ*2, Δ*6, Δ*17 and Δ*20 Pet truncations are shown wh
and Δ*19 are omitted. Abbreviations are the same as in Figure 1. (B and C
Pic (C) chimeras expressed in E. coli TOP10. The TCA-precipitated culture su
anti-ESAT6. The equivalent OM fractions demonstrating the presence of themedium (Figure 4). ESAT-6 secreted by this Pet frag-
ment contains only the 9 amino acids of the wild-type
Pet passenger domain α-helix that are adjacent to the
cleavage site. Two recent reports implicated a con-
served tryptophan residue (W985) in the AC domain in
secretion of some SPATEs [33,34]. Interestingly,
ESAT6-PetΔ*17 to Δ*20 proteins lack the predicted Pet
AC domain altogether but are well secreted (Figure 4).
To further test a role for W985 in secretion, this amino
acid and three other conserved and closely positioned
residues (I983, L987 and G989) were mutated to Ala
and Lys in the secretion-competent ESAT6-PetΔ*6. All
mutated proteins were secreted into the growth medium
as efficiently as the ESAT6-PetΔ*6 and retained a cleaved
β-domain in the OM (Additional file 7: Figure S6). These
data further support the view that the AC domain is not
required for secretion per se but is essential for folding of
native AT polypeptides.
Next we investigated whether other SPATE proteins
could support secretion of heterologous proteins in a
manner analogous to Pet. Pic [35] belongs to a clade of
the SPATEs that is evolutionarily distinct from that har-
bouring Pet. Alignment of Pet and Pic protein sequences
from the beginning of the predicted AC domains shows
68% identity and 80% similarity (Additional file 8:
Figure S7). Based on the alignment we constructed
ESAT6-Pic fusions containing C-terminal Pic fragmentsC
n of heterologous proteins to the culture supernatant fraction.
d to determine the minimal C-terminal Pet fragment capable of ESAT-6
ile for simplicity the intermediate variants Δ*3–Δ*5, Δ*7–Δ*16, Δ*18
) Detection by western immunoblotting of ESAT6-Pet (B) and ESAT6-
pernatants were analysed by SDS-PAGE and probed with polyclonal
cleaved β-barrel in the OM are shown in Additional file 6: Figure S5.
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Pic fusions were efficiently secreted (Figure 4C) allow-
ing us to conclude that β-barrels from SPATE proteins
other than Pet can be used to secrete proteins to the
culture medium.
Discussion
E. coli was the first organism to be used for industrial
scale production of recombinant proteins. Since then, a
large number of proteins produced in E. coli have success-
fully reached the market including human interferons,
interleukins, and granulocyte stimulating factor. However,
the dominance of E. coli in industrial bioprocessing is
waning with only ca. 40% of new recombinant protein
pharmaceuticals being produced using prokaryotic cells.
The diminution of E. coli is strongly related to that fact
that strains of E. coli used for industrial scale protein pro-
duction do not effectively secrete proteins into the extra-
cellular environment. Solutions to this problem would
effectively reposition E. coli as the host of choice for in-
dustrial recombinant protein production. To achieve se-
lective accumulation of recombinant proteins in the
extracellular milieu, a Gram-negative protein secretion
system must be harnessed. While secretion of heterol-
ogous proteins through the Type 1–3 systems has been
achieved, the complexity of these systems limits the nature
and size of the proteins that can be targeted for secretion.
The work described here demonstrates that an AT mod-
ule, based on SPATE proteins, can be used for the targeted
secretion of chimeric proteins into the culture media of
Gram-negative bacteria. Importantly, we have demon-
strated that this platform may be used for the specific
accumulation of folded heterologous proteins with
functional, structural and size heterogeneity and for
multicomponent complexes (Figure 1). The ability to
selectively accumulate target proteins in the culture
medium, away from the majority of the process im-
purities associated with expression in other compart-
ments, makes this system attractive for adoption in
industrial RPP applications since extracellular expres-
sion of proteins in a folded active form enables sim-
plification of the purification process and significantly
reduces downstream processing. However, effective
utilisation of the AT module for generalised RPP
necessitates achieving yields of target proteins at in-
dustrial scale and at concentrations competitive with
alternative technologies. Importantly, the yields
achieved here are consistent with levels achieved for
other E. coli protein secretion systems [1,36]. How-
ever, in the experiments conducted here, only ~ 50%
of the expressed protein is targeted to the extracellu-
lar milieu, the remainder accumulating at the outer
membrane. Furthermore, these yields were obtained
in small-scale non-optimised conditions. Thus, anoptimised secretion platform, in a controlled opti-
mised fermentation process, would be expected to
generate higher protein yields.
Live attenuated bacterial vectors offer the opportunity to
deliver vaccine candidates inside human cells thereby eli-
citing a protective immune response against both infec-
tious and non-infectious disease e.g. tumours. While the
induction of antibody has been demonstrated in many ani-
mal models, the anticipated induction of cell-mediated im-
munity has been disappointing [37]. There are several
reasons for this including (1) inefficient production of the
recombinant heterologous antigen and (2) after invading
professional phagocytic cells the live vector remains in the
phagosome such that its antigens do not reach the cyto-
solic processing pathway. Surface display of AT-fusions in
live-attenuated vaccine strains offers potential to overcome
these problems [14]. Here we have demonstrated that the
AT-module can be used in conjunction with live-
attenuated Salmonella strains and demonstrated the suc-
cessful surface display of folded functional heterologous
proteins (Figure 2 and 3). Unfortunately, previous experi-
ments using surface display have also failed to induce sub-
stantial protective immunity [14]. However, the ability of
live attenuated vectors to secrete antigens intracellularly
may enhance presentation of the antigens to the immune
system and provide the desired protective response [38].
Thus, our demonstrated expression of secreted heterol-
ogous protein constructs in live attenuated Salmonella
strains offers the possibility of developing a platform for
the delivery of multivalent vaccines based on the continu-
ous secretion of proteins in vivo in which significant cell
mediated immunity is generated.
Finally, this work reveals novel insight into the biology
of the AT secretion system. Several articles have described
the importance of specific amino acid residues for the se-
cretion of passenger domain proteins notably residues
present in the AC domain [33,34]. Indeed, recent investi-
gations of BrkA suggested that during secretion portions
of the AC domain are sequestered by a specific domain
within the β-barrel which initiates translocation of the pas-
senger domain to the external environment [39]. Work
provided here clearly demonstrates that the AC domain is
not essential for secretion since the smallest secretion-
competent constructs completely lack this domain and
mutations within the domain do not affect secretion levels
(Figure 4 and Additional file 8: Figure S7). These investiga-
tions reinforce the concept that the AC domain is required
specifically for folding of the β-helical passenger domain,
although folding of the passenger domain may enhance
the rate at which secretion occurs [30].
Conclusions
In conclusion, we have developed a versatile platform,
based on an AT module, which can be used for
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medium in a soluble folded form. Additionally, this sys-
tem can be used for surface display of heterologous
fusions on the bacterial cell surface.
Methods
Bacterial strains and growth conditions
E. coli strains TOP10 (Invitrogen), NEB 5αF’Iq and
JM110 (NEB) were used for cloning. E. coli TOP10,
TOP10 dsbA [26] and BL21* (Novagen) and S. enterica
SL1344 and SL3261 strains [40] were used for protein
expression and secretion. Bacteria were grown at 37°C
in Luria-Bertani liquid or solid media supplemented
with carbenicillin (100 and 80 μg/ml, respectively) or
kanamycin (50 μg/ml) when appropriate. Protein ex-
pression was induced by adding anhydrotetracycline
(200 μg/l) or IPTG (0.5 mM) as appropriate and the cul-
tures were incubated for a further 1.5–2 h.
General molecular biology techniques and plasmid
construction
Recombinant DNA manipulations were described else-
where [41]. Phusion High-Fidelity DNA polymerase
(Finnzymes), DNA modifying enzymes, plasmid mini-
prep and PCR/gel extraction kits (Fermentas, Qiagen
and NEB) were used according to the manufacturer’s
instructions. Oligonucleotides were synthesized by Alta
Bioscience and Eurogentec. Sequencing, mass spec-
trometry, flow cytometry and gel imaging/densitometry
were done using the University of Birmingham Func-
tional genomics facility. Codon optimization for the
most commonly used codons and de novo synthesis of
DNA was done by GenScript, GenArt or Epoch Life
Science. Alignments were generated with ClustalX [42]
and phylogenetic trees generated with Geneious soft-
ware (http://www.geneious.com/).
Plasmids used in this study are listed in Additional
file 9: Table S2. Primers used for PCR are listed in Add-
itional file 10: Table S3. To construct pASK-Pet, the pet
gene was PCR-amplified from pBAD-Pet with BsaI-pet-
F and HindIII-pet-R primers and cloned between BsaI/
HindIII sites in pASK-IBA33plus (IBA BioTAGnology).
pET-Pet was constructed by cloning the pet gene into
the NdeI-HindIII sites of pET22b. pASK-His6-Pet and
pASK-His6-Pet-ΔD1 were constructed by replacing the
SacI-BglII or SacI-BstBI pet fragment in pASK-Pet with
an amplicon generated by PCR with SacI-pet-F and
PetSS-BglII-AflII-BstBI-R primers, the latter encoding a
His6-tag sequence. To construct pet chimeras the heter-
ologous genes were amplified by PCR using appropriate
primer pairs and relevant DNA templates listed in Add-
itional file 2: Figure S2. The PCR-amplified heterol-
ogous genes were cloned between BglII/BstBI and
BglII/PstI sites in the pet gene in pASK-Pet, pASK-Pet*or pET-Pet. pASK-Ag85B-ESAT6-Pet was constructed
by inserting PCR-amplified esxA gene (ESAT-6) be-
tween BstBI-PstI sites in pASK-Ag85B-Pet-BB. Con-
structs pASK-ESAT6-Pet Δ*1 to Δ*20 were made by
replacing the PstI-HindIII fragment in pASK-ESAT6-
Pet-BP with the shorter pet gene fragments generated
by PCR with one of the forward primers (PstI-TSYQ-
del1-F to PstI-YKAF-del20-F) and HindIII-pet-R as
a reverse primer. Equivalent constructs encoding
ESAT6-Pic chimeras were generated by replacing the
PstI-HindIII pet fragment in pASK-ESAT6-Pet-BP with
the pic fragment amplified from pPic1 [35] using one of
the forward primers SbfI-FKAG-Pic-del6-F to SbfI-
YKNF-Pic-del20-F) and HindIII-Pic-end-R as a reverse
primer. Codons encoding I974, W985, L987 and G989
were mutated by site directed mutagenesis using pri-
mers BglII-ESAT6-F and HindIII-pet-R as previously
described [43]. All constructs generated in this study
were sequenced to confirm the veracity of the nucleo-
tide modifications.
Preparation and analysis of proteins
Proteins were visualised by Coomassie staining after
SDS-PAGE on standard [44] or precast (Precise 4-20%
Tris/HEPES, ThermoFisher; NuPAGE 4-12% Bis-Tris/
MES, Invitrogen) polyacrylamide protein gels or by
western immunoblotting as previously described [45].
Rabbit polyclonal antibodies against Pet passenger do-
main (1:5000 dilution) [46], ESAT-6 (Abcam; 1:2000
dilution) and mCherry (anti-RFP, Abcam; 1:2000) were
used for western immunoblotting. Secondary alkaline
phosphatase-conjugated goat anti-rabbit antibodies
and NBT/BCIP (Nitro blue tetrazolium chloride/5-
Bromo-4-chloro-3-indolylphosphate) substrate were
purchased from Sigma. Protein concentrations were
determined spectrophotometrically and by SDS-PAGE
comparisons with known quantities of purified protein:
Bovine serum albumin, Ovalbumin and Lysozyme
(Sigma).
Cellular fractions were prepared essentially as
described previously [44]. His6-tagged proteins were
purified by affinity chromatography on Ni-agarose
following manufacturer’s instructions (WebScientific).
Briefly, 400 ml cultures were grown and protein
expression was induced as described above. Culture
supernatants were harvested and sterilised as above,
supplemented with 1 mM PMSF and then concen-
trated through Vivaspin centrifugation device (Sartorius).
The concentrated supernatant fractions were passed over
a Ni-agarose affinity chromatography column under na-
tive conditions using 50 mM sodium phosphate, 500 mM
NaCl, 10 mM imidazole (pH7.5) as binding buffer and
50 mM sodium phosphate, 500 mM NaCl, 500 mM
imidazole (pH7.5) as elution buffer.
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were diluted in 1 ml filter-sterilised Dulbecco’s PBS sup-
plemented with 10 μl of working solutions of PI and
BOX (5 and 10 μg/ml respectively; Sigma) and analysed
immediately on FACSAria II (BD Biosciences) using
488 nm laser [47]. Side and forward scatter data and
fluorescence data from 104 particles were collected. Op-
tical filters used to measure green and red fluorescence
were 502LP, 530/30BP (FITC) and 610LP, 616/23BP (PE-
Texas Red), respectively. To analyse surface localisation
of proteins by indirect flow cytometry, cells were washed
in PBS and incubated at RT with 1% BSA in PBS. Cells
were then incubated for 1 h at RT with primary anti-
body diluted in PBS (anti-Pet, 1:500; anti-ESAT6, 1:500;
anti-mCherry, 1:800) followed by 3 PBS washes and final
incubation with Alexa FluorW 488 goat anti-rabbit IgG
(1:500; Invitrogen). Cells were washed as before and ana-
lysed on a FACSAria II as above.
Proteins in live or fixed bacterial cells were detected
by indirect Immunofluorescence as previously described
[26]. Cells were visualized using either phase contrast
or fluorescence using a Leica DMRE fluorescence
microscope-DC200 digital camera system. Exposure
time was 118 ms. The Garen and Levinthal [48] assay of
Alkaline Phosphatase activity was used based on con-
version of p-nitrophenylphosphate (pNPP) substrate
into yellow product with absorbance at 410 nm. Far-UV
CD measurements from 190 to 260 nm were collected
on a JASCO J-715 spectropolarimeter at room
temperature, as described previously [26]. Protein
structures were modelled in Swiss-Model [49] or Phyre
[50] and were visualised using PyMol (http:\\www.
pymol.org). Secondary structures were predicted with
PsiPred [51].Additional files
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